Abstract
Direct Medical Cost of Treatment of uncomplicated malaria after the Adoption of artemisinin-Based Combination Therapy in Nigeria
Highlights
As a low- and middle-income country, Nigeria faces the health burden caused by communicable diseases, such as malaria (Babamale and Ugbomoiko, 2016), in addition to that produced by noncommunicable diseases, such as cardiovascular diseases (Maiyaki and Garbati, 2014)
The average direct medical cost incurred per patient for the treatment of uncomplicated malaria treatment was 2,234.07 ± 1,307 NGN (US $5.8) which accounts for 12.4% of the national minimum wage earnings
The direct cost of malaria treatment was high contributing to the significant economic burden even after the adoption of artemisinin combination therapies (ACTs) in Nigeria
Summary
As a low- and middle-income country, Nigeria faces the health burden caused by communicable diseases, such as malaria (Babamale and Ugbomoiko, 2016), in addition to that produced by noncommunicable diseases, such as cardiovascular diseases (Maiyaki and Garbati, 2014). 50% of this is shared by only six countries of which Nigeria is inclusive (World Health Organization, 2019). Malaria for a long time has been considered a disease of poverty as well as one that aggravates poverty because it is predominantly transmitted in the regions of low to middle income including Nigeria (Worrall et al, 2005). It affects the health and wealth of nations (Okorosobo et al, 2011). Poverty is a risk factor for malaria because people with low income have a lower health-seeking attitude for effective, prompt medical care and are less likely to have access to the means of disease prevention (Xia et al, 2016)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
